Comparative Analysis of the Effects of Antimuscarinic Agents on Bladder Functions in Both Nonhuman Primates and Rodents
Authors:
- Hiroshi NagabukuroHNHiroshi Nagabukuro
- Katherine L. VillaKVKatherine L. Villa
- L. Alexandra WickhamLWL. Alexandra Wickham
- Alison A. KulickAKAlison A. Kulick
- Loise GichuruLGLoise Gichuru
- Marcie J. DonnellyMDMarcie J. Donnelly
- Gregory O. VoroninGVGregory O. Voronin
- Tony PereiraTPTony Pereira
- Xinchun TongXTXinchun Tong
- Andrew NicholsANAndrew Nichols
- Stephen E. AlvesSAStephen E. Alves
- Gary P. O’nEillGOGary P. O’nEill
Open Access
- 1 July 2011
- journal article
- research article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 338 (1) , 220-227
Abstract
Both the physiological role of muscarinic receptors for bladder function and the therapeutic efficacy of antimuscarinic agents for overactive bladder syndrome are well documented. We investigated the effect of antimuscarinic agents with different subtype selectivity on urodynamic parameters in nonhuman primates and rodents and compared plasma levels of these agents between species. Anesthetized rhesus monkeys were transurethrally catheterized, and the bladder was infused with saline. Urodynamic parameters were measured before and after intravenous drug administration. Tolterodine (nonselective) and oxybutynin (moderately M3-selective) increased bladder capacity at lower doses than those required to decrease micturition pressure. However, higher doses of darifenacin (M3-selective) were needed to increase the bladder capacity than those needed to decrease the micturition pressure. In rats, tolterodine had no effect on the bladder capacity but decreased the micturition pressure at all of the doses administered. Oxybutynin also decreased micturition pressure and increased bladder capacity at the highest dose. Plasma levels of these drugs overlap in both species. These results suggest that, in addition to the M3 receptor, other muscarinic receptor subtypes contribute to regulate bladder storage function in nonhuman primates, since less subtype-selective tolterodine and oxybutynin showed higher specificity to the bladder capacity effect than the effect on micturition pressure compared with M3-selective darifenacin. In addition, the role of muscarinic receptors in bladder storage function varies between primates and rodents. Compared with rodents, muscarinic receptors may play a more active role during the storage phase to regulate the functional bladder capacity in primates.Keywords
This publication has 37 references indexed in Scilit:
- Effective Treatment of Neurogenic Detrusor Dysfunction by Combined High-Dosed Antimuscarinics without Increased Side-EffectsEuropean Urology, 2008
- Muscarinic receptor antagonists for overactive bladderBJU International, 2007
- Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladderBritish Journal of Pharmacology, 2006
- Systemic oxybutynin decreases afferent activity of the pelvic nerve of the rat: New insights into the working mechanism of antimuscarinicsNeurourology and Urodynamics, 2005
- Urodynamic effects of oxybutynin and tolterodine in conscious and anesthetized rats under different cystometrographic conditionsBMC Pharmacology, 2005
- Intravesical Oxybutynin: A Local Anesthetic Effect on Bladder C AfferentsJournal of Urology, 2003
- Antimuscarinics and the Overactive Detrusor—Which Is the Main Mechanism of Action?European Urology, 2003
- The minor population of M3‐receptors mediate contraction of human detrusor muscle in vitroJournal of Autonomic Pharmacology, 2001
- Effects of Anesthesia on Urodynamic Studies in the Primate ModelJournal of Urology, 1996
- Bladder Electromyograms and Function in Monkeys after AtropineBritish Journal of Urology, 1985